COLLEGIUM PHARMACEUTICAL, INC
Ticker: 1267565
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY2026 | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 199.88+3.3% | 193.52-7.6% | 209.36+11.4% | 188.00+5.8% | 177.76+11.6% | 159.30+9.7% | 145.28+0.2% | 144.92 |
| Total Income | 199.88+3.3% | 193.52-7.6% | 209.36+11.4% | 188.00+5.8% | 177.76+11.6% | 159.30+9.7% | 145.28+0.2% | 144.92 |
| EXPENSES | ||||||||
| Expenditure | 196.18+20.6% | 162.62+10.4% | 147.27-3.7% | 152.90-2.0% | 156.07+25.4% | 124.46+27.2% | 97.81+2.5% | 95.45 |
| Tax | 1.52-64.2% | 4.24-64.5% | 11.93+136.7% | 5.04+609.9% | 0.71-88.6% | 6.25-34.1% | 9.49+6.5% | 8.91 |
| PROFIT | ||||||||
| PBT | -13.53-172.2% | 18.74-56.9% | 43.44+155.1% | 17.03+445.8% | 3.12-80.0% | 15.58-46.5% | 29.10-20.5% | 36.62 |
| Net Profit | -15.05-203.8% | 14.50-54.0% | 31.51+163.0% | 11.98+395.0% | 2.42-74.1% | 9.34-52.4% | 19.61-29.2% | 27.71 |
| KEY METRICS | ||||||||
| OPM % | 1.85%-14.12pp | 15.96%-13.69pp | 29.66%+10.98pp | 18.67%+6.47pp | 12.20%-9.67pp | 21.87%-10.81pp | 32.68%-1.46pp | 34.14% |
| NPM % | -7.53%-15.02pp | 7.49%-7.56pp | 15.05%+8.68pp | 6.37%+5.01pp | 1.36%-4.50pp | 5.86%-7.64pp | 13.50%-5.63pp | 19.12% |
| EPS | -0.46-202.2% | 0.45-55.0% | 1.00+163.2% | 0.38+375.0% | 0.08-72.4% | 0.29-51.7% | 0.60-30.2% | 0.86 |
Corporate Events
Board MeetingCOLL
202614May
Board Meeting
2026 Annual Meeting of Shareholders to elect directors, appr…
SEC Filing ↗ Board MeetingCOLL
202611May
Board Meeting
Board adopted 2026 Inducement Plan; Scott Dreyer (EVP & CCO)…
SEC Filing ↗ Board MeetingCOLL
20262Apr
Board Meeting
Director Nomination & Retirement — Michael Donovan nominated…
SEC Filing ↗